Sub menu

Vaccines

Typhim Vi

Details for Typhim Vi vaccine and its components.

Recently added

This page was added on 04 June 2018.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Vaccine group
Monovalent vaccines
Description:

Registered for use in people aged ≥2 years.

Monovalent parenteral Vi polysaccharide typhoid vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 0.025 mg purified Vi capsular polysaccharide of Salmonella typhi strain Ty2
  • <1.25 mg phenol

For Product Information and Consumer Medicine Information about Typhim Vi visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
Typhoid fever

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/typhim-vi

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.